Press Release

Date: 08 July 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS Sub: Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015– Acquisition of ABCnow GmbH. Dear Sirs/Madam, Kindly be informed that Marksans Pharma Limited has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a Germany based pharmaceutical company with front- end sales, marketing, and distribution capabilities across German healthcare market. The acquisition marks a strategic step in expanding Marksans' presence across regulated European markets and strengthening its forward-integration strategy through direct, owned market-access capabilities in the European Union. Enclosed herewith please find details required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 9, 2015 given in Annexure A to this letter. For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Enclosed as above Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com Annexure A Disclosure under Para (A) of Part (A) of Schedule III to the Regulation 30 SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Sr. Details of Events that need to be provided Information of such events(s) 1 Name of the target entity, details in brief ABCnow GmbH is a foreign company registered in such as size, turnover etc. Germany. It is a pharmaceutical wholesale and distribution company headquartered in Flensburg, Germany. It is primarily engaged in marketing & distribution of OTC products in Germany. It has a turnover of € 227,233.69 as on December 31, 2025. 2 Whether the acquisition would fall within The transaction is between the Company and the related party transaction(s)and whether the shareholders of ABCnow GmbH, who are not promoter/ promoter group/ group companies related party to the Company. As such, the have any interest in the entity being transaction will not fall within related party acquired? transaction(s) for the Company. If yes, nature of interest and details thereof Further, promoter/promoter group of the Company and whether the same is done at “arm’s have no interest in ABCnow GmbH. length” 3 Industry to which the entity being acquired ABCnow GmbH is a pharmaceutical wholesale and belongs distribution company headquartered in Flensburg, Germany. 4 Objects and effects of acquisition (including This acquisition will enable Marksans to use the but not limited to, disclosure of reasons for front-end sales and marketing infrastructure of acquisition of target entity, if its business is ABCnow GmbH for marketing its products outside the main line of business of the manufactured in India, UK, and USA regions. It listed entity) will bolster Marksans’ presence in the European markets. 5 Brief details of any governmental or No approval will be required for the acquisition. regulatory approvals required for the acquisition 6 Indicative time period for completion of the The acquisition is expected to be completed by 31 acquisition July 2026. 7 Nature of consideration -whether cash Cash consideration consideration or share swap and details of the same 8 Cost of acquisition or the price at which the The Company will acquire entire shareholding of shares are acquired ABCnow GmbH for a total consideration of € 892,384. 9 Percentage of shareholding / control The Company will acquire 100% share capital of acquired and / or number of shares acquired ABCnow GmbH. 10 Brief background about the entity acquired ABCnow GmbH is a pharmaceutical wholesale and in terms of products/line of business distribution company headquartered in Flensburg, acquired, date of incorporation, history of Germany. It is primarily engaged in marketing & last 3 years turnover, country in which the distribution of OTC products in Germany. acquired entity has presence and any other ABCnow presents an attractive opportunity to gain significant information (in brief) access to German pharma markets and with its capable and well-trained team of professionals can support Marksans’ growth aspirations. With this acquisition, Marksans will create its own front end in Germany to market its products. It was incorporated in the year 2023 and it achieved revenue of € 510,215.60 in 2024 and € 227,233.69 in 2025. Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com